Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An 8-week Multicenter Study to Evaluate the Efficacy and Safety of Orally Administered Valsartan/Amlodipine Combination Based Therapy Versus Amlodipine Monotherapy in Patients With Stage II Hypertension

NCT00350168 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00350168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00350168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An 8-week Multicenter Study to Evaluate the Efficacy and Safety of Orally Administered Valsartan/Amlodipine Combination Based Therapy Versus Amlodipine Monotherapy in Patients With Stage II Hypertension
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2006
Completion date
April 30, 2007
Enrollment
647 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension